drugset / Trial / NCT04643600
The Effect of Orally Administered L- Arginine on Quadriceps Strenght in Healthy Smokers
RandomizedCrossoverSingle-blindPrevention
Summary
The study will investigate changes in certain locomotor parameters as early predictors of disease in smokers who are prone to develop chronic obstructive pulmonary disease (COPD).
Timeline
- Start
- 2019-03-01
- Primary completion
- 2022-02-15
- Completion
- 2022-02-17
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | L-arginine | Small molecule | 500 mg | Oral |
Indications
No indication recorded.